Form D · Biotechnology
NurExone Biologic Inc.
Technion City, Haifa, L3 · CIK 0001995074
Offering snapshot reported Aug 21, 2026 · SEC filing
- Reported sold
- $450K Offering amount: $450K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 20, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2026 | Initial | $450,456 | No comparison | 2 | SEC filing |
| Jul 2, 2026 | Initial | $441,779 | No comparison | 2 | SEC filing |
| Mar 18, 2026 | Initial | $279,910 | No comparison | 4 | SEC filing |
| Aug 27, 2025 | Initial | $147,846 | No comparison | 1 | SEC filing |
| Apr 22, 2025 | Initial | $1,627,604 | No comparison | 1 | SEC filing |
| Jan 22, 2025 | Initial | $434,512 | No comparison | 6 | SEC filing |
| Mar 25, 2024 | Initial | $430,296 | No comparison | 5 | SEC filing |
| Mar 25, 2024 | Initial | $1,018,224 | No comparison | 4 | SEC filing |
| Mar 25, 2024 | Initial | $42,634 | No comparison | 1 | SEC filing |
| Jan 9, 2024 | Initial | $1,111,542 | No comparison | 3 | SEC filing |
| Oct 2, 2023 | Initial | $742,166 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594958
CDN$622,692.95. Based on the Bank of Canada exchange rate of 0.7234 on August 19, 2026. Consists of the issuance of 1,132,169 units.
Source: Form D, filed Aug 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yoram Drucker | Director, Executive |
| Eyal Gabbai | Director |
| Oded Orgil | Director |
| Eran Ovadya | Executive |
| James Richardson | Director |
| Gadi Riesenfeld | Director |
| Lior Shaltiel | Director, Executive |
| David Stolick | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Minus 1 Entry, Ground Floor Of Bldg B Gutwirth Industrial Park
Technion City, Haifa, L3, 3200003
Phone: 972 52-4803034
Technion City, Haifa, L3, 3200003
Phone: 972 52-4803034